Bio Plus Co., Ltd (KOSDAQ:099430)

Market Cap	288.93B -38.3%
Revenue (ttm)	94.42B +18.4%
Net Income	14.00B -28.6%
EPS	133.44 -60.3%
Shares Out	61.54M
PE Ratio	35.18
Forward PE	n/a
Dividend	70.00 (1.64%)
Ex-Dividend Date	Dec 29, 2025

Volume	511,965
Open	4,300.00
Previous Close	4,265.00
Day's Range	4,300.00 - 4,705.00
52-Week Range	4,235.00 - 8,350.00
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2003
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 099430

Financial Performance

In 2025, Bio Plus's revenue was 90.90 billion, an increase of 36.87% compared to the previous year's 66.41 billion. Earnings were 15.00 billion, an increase of 6.01%.